Treatment of acute lymphoblastic leukaemia in children is one of the great success stories of cancer medicine. Genetic analysis continues to have a major role in the fight against this and other lymphoid leukaemias.
Leukaemia is a cancer specifically of white blood cells (leucocytes). In common with the other formed elements in blood, white cells are derived from the multipotential haemopoietic stem cell in bone marrow, and leukaemia is characterised by the accumulation of malignant white cells in bone marrow and blood, at the expense of normal blood cell production.
There are four main leukaemia types, which define both the speed of disease progression (acute or chronic) and the type of white cell malignantly transformed (myeloid or lymphoid), and these are chronic myeloid, chronic lymphoid (both slowly progressive), acute myeloid and acute lymphoblastic (both rapidly progressive).
Of the four types, acute lymphoblastic leukaemia (ALL) is the least common overall but the most common to affect children. In fact, ALL is the most common cancer of any type to occur in childhood, and accounts for 85% of all cases of childhood leukaemia, the peak incidence of ALL being between the ages of three and seven years.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.